Combination chemoprophylaxis and immunoprophylaxis in reducing the incidence of leprosy
Malcolm S Duthie,1 Marivic F Balagon2 1Infectious Disease Research Institute, Seattle, WA, USA; 2Cebu Skin Clinic, Leonard Wood Memorial Center for Leprosy Research, Cebu City, the Philippines Abstract: Leprosy is a complex infectious disease caused by Mycobacterium leprae that is a leading cause of...
Saved in:
Main Authors: | Duthie MS (Author), Balagon MF (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2016-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Trend analysis of leprosy in Morocco between 2000 and 2017: Evidence on the single dose rifampicin chemoprophylaxis.
by: Ibtissam Khoudri, et al.
Published: (2018) -
Chemoprophylaxis of Tropical Infectious Diseases
by: William J. H. McBride
Published: (2010) -
An innovative approach to screening and chemoprophylaxis among contacts of leprosy patients in low endemic settings: experiences from Cambodia.
by: Arielle Cavaliero, et al.
Published: (2019) -
IMMUNOPROPHYLAXIS OF CANCER OF THE CERVIX UTERI
by: V. P. Kozachenko, et al.
Published: (2014) -
PROBLEMS AND PERSPECTIVES OF IMMUNOPROPHYLAXIS IN RUSSIA
by: V.К. Tatochenko
Published: (2009)